Such an in situ imaging mechanism allows nanodevice to be used as an imaging agent and urinalysis tracers to non‐invasively diagnose the onset of AKI at least 6 h earlier than Kim‐1 urinalysis, at 12 h earlier than sCr and BUN further underlines their potential in clinical translation. This evidence concerns the gene HAVCR1 and acute kidney injury.